Búsqueda | Biblioteca Virtual en Salud

1.

[Calcified coronary artery disease and serum markers].

Mori, Katsuhito; Jono, Shuichi.

Clin Calcium ; 17(3): 340-5, 2007 Mar.

Artículo en Japonés | MEDLINE | ID: mdl-17339737

2.

Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages.

Shioi, Atsushi; Katagi, Miwako; Okuno, Yasuhisa; Mori, Katsuhito; Jono, Shuichi; Koyama, Hidenori; Nishizawa, Yoshiki.

Circ Res ; 91(1): 9-16, 2002 Jul 12.

Artículo en Inglés | MEDLINE | ID: mdl-12114316

3.

Serum levels of 1-84 and 7-84 parathyroid hormone in predialysis patients with chronic renal failure measured by the intact and bio-PTH assay.

Tsuchida, Takao; Ishimura, Eiji; Hirowatari, Kaname; Matsumoto, Naoki; Imanishi, Yasuo; Jono, Shuichi; Miki, Takami; Inaba, Masaaki; Nishizawa, Yoshiki.

Nephron Clin Pract ; 102(3-4): c108-14, 2006.

Artículo en Inglés | MEDLINE | ID: mdl-16286785

4.

Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease.

Jono, Shuichi; Ikari, Yuji; Shioi, Atsushi; Mori, Katsuhito; Miki, Takami; Hara, Kazuhiro; Nishizawa, Yoshiki.

Circulation ; 106(10): 1192-4, 2002 Sep 03.

Artículo en Inglés | MEDLINE | ID: mdl-12208791

5.

Cross-sectional association of serum phosphate with carotid intima-medial thickness in hemodialysis patients.

Ishimura, Eiji; Taniwaki, Hiromichi; Tabata, Tsutomu; Tsujimoto, Yoshihiro; Jono, Shuichi; Emoto, Masanori; Shoji, Tetsuo; Inaba, Masaaki; Inoue, Takashi; Nishizawa, Yoshiki.

Am J Kidney Dis ; 45(5): 859-65, 2005 May.

Artículo en Inglés | MEDLINE | ID: mdl-15861351

6.

Increased levels of serum osteoprotegerin in hypothyroid patients and its normalization with restoration of normal thyroid function.

Nagasaki, Toshiki; Inaba, Masaaki; Jono, Shuichi; Hiura, Yoshikazu; Tahara, Hideki; Shirakawa, Kumi; Onoda, Naoyoshi; Ishikawa, Tetsuro; Ishimura, Eiji; Nishizawa, Yoshiki.

Eur J Endocrinol ; 152(3): 347-53, 2005 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-15757850

7.

Hyperphosphatemia and vascular calcification in end-stage renal disease.

Nishizawa, Yoshiki; Jono, Shuichi; Ishimura, Eiji; Shioi, Atsushi.

J Ren Nutr ; 15(1): 178-82, 2005 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-15648030

8.

[Clinical significance of PTH (1-84) and PTH (7-84) in patients with predialysis chronic renal failure in relation to bone metabolism markers].

Tsuchida, Takao; Ishimura, Eiji; Hirowatari, Kaname; Matsumoto, Naoki; Jono, Shuichi; Miki, Takami; Inaba, Masaaki; Nishizawa, Yoshiki.

Clin Calcium ; 15 Suppl 1: 156-60; discussion 160, 2005 Sep.

Artículo en Japonés | MEDLINE | ID: mdl-16272650

9.

Matrix Gla protein is associated with coronary artery calcification as assessed by electron-beam computed tomography.

Jono, Shuichi; Ikari, Yuji; Vermeer, Cees; Dissel, Paul; Hasegawa, Kotaro; Shioi, Atsushi; Taniwaki, Hiromichi; Kizu, Akane; Nishizawa, Yoshiki; Saito, Shigeru.

Thromb Haemost ; 91(4): 790-4, 2004 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-15045141

10.

C-reactive protein is a significant predictor of vascular calcification of both aorta and hand arteries.

Ishimura, Eiji; Okuno, Senji; Kitatani, Kayoko; Maekawa, Kiyoshi; Izumotani, Tsuyoshi; Yamakawa, Tomoyuki; Jono, Shuichi; Shoji, Tetsuo; Shioi, Atsushi; Inaba, Masaaki; Massry, Shaul G; Nishizawa, Yoshiki.

Semin Nephrol ; 24(5): 408-12, 2004 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-15490400

11.

[Risk factors of atherosclerosis in end-stage renal disease patients].

Jono, Shuichi.

Clin Calcium ; 14(1): 21-6, 2004 Jan.

Artículo en Japonés | MEDLINE | ID: mdl-15576949

12.

[Vascular calcification and phosphate metabolism].

Jono, Shuichi.

Clin Calcium ; 12(8): 1067-72, 2002 Aug.

Artículo en Japonés | MEDLINE | ID: mdl-15775397

13.

[Mechanism of vascular calcification].

Kizu, Akane; Jono, Shuichi.

Clin Calcium ; 14(6): 92-6, 2004 Jun.

Artículo en Japonés | MEDLINE | ID: mdl-15577061

14.

[Close relationship between bone and vasculature].

Jono, Shuichi; Nishizawa, Yoshiki.

Clin Calcium ; 12(3): 321-6, 2002 Mar.

Artículo en Japonés | MEDLINE | ID: mdl-15775309

15.

[Measurement of serum MGP].

Jono, Shuichi; Nishizawa, Yoshiki.

Clin Calcium ; 12(8): 1102-4, 2002 Aug.

Artículo en Japonés | MEDLINE | ID: mdl-15775403

16.

[Osteopontin and atherosclerosis].

Jono, Shuichi.

Nihon Rinsho ; 63 Suppl 10: 635-40, 2005 Oct.

Artículo en Japonés | MEDLINE | ID: mdl-16279715

17.

Association of serum TRAIL level with coronary artery disease.

Mori, Katsuhito; Ikari, Yuji; Jono, Shuichi; Shioi, Atsushi; Ishimura, Eiji; Emoto, Masanori; Inaba, Masaaki; Hara, Kazuhiro; Nishizawa, Yoshiki.

Thromb Res ; 125(4): 322-5, 2010 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-20034655

18.

Fetuin-A is associated with calcified coronary artery disease.

Mori, Katsuhito; Ikari, Yuji; Jono, Shuichi; Emoto, Masanori; Shioi, Atsushi; Koyama, Hidenori; Shoji, Tetsuo; Ishimura, Eiji; Inaba, Masaaki; Hara, Kazuhiro; Nishizawa, Yoshiki.

Coron Artery Dis ; 21(5): 281-5, 2010 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-20436350

19.

Effects of pravastatin on serum osteoprotegerin levels in patients with hypercholesterolemia and type 2 diabetes.

Mori, Katsuhito; Jono, Shuichi; Emoto, Masanori; Kawagishi, Takahiko; Yasumoto, Hideo; Konishi, Toshiaki; Furumitsu, Yutaka; Shioi, Atsushi; Shoji, Tetsuo; Inaba, Masaaki; Nishizawa, Yoshiki.

Angiology ; 61(1): 86-91, 2010.

Artículo en Inglés | MEDLINE | ID: mdl-19147525

20.

Vascular calcification in chronic kidney disease.

Jono, Shuichi; Shioi, Atsushi; Ikari, Yuji; Nishizawa, Yoshiki.

J Bone Miner Metab ; 24(2): 176-81, 2006.

Artículo en Inglés | MEDLINE | ID: mdl-16502129

Biblioteca Virtual en Salud

Hipertensión

Su selección (0)

Formato de exportación:

Exportar:

[Calcified coronary artery disease and serum markers].

Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages.

Serum levels of 1-84 and 7-84 parathyroid hormone in predialysis patients with chronic renal failure measured by the intact and bio-PTH assay.

Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease.

Cross-sectional association of serum phosphate with carotid intima-medial thickness in hemodialysis patients.

Increased levels of serum osteoprotegerin in hypothyroid patients and its normalization with restoration of normal thyroid function.

Hyperphosphatemia and vascular calcification in end-stage renal disease.

[Clinical significance of PTH (1-84) and PTH (7-84) in patients with predialysis chronic renal failure in relation to bone metabolism markers].

Matrix Gla protein is associated with coronary artery calcification as assessed by electron-beam computed tomography.

C-reactive protein is a significant predictor of vascular calcification of both aorta and hand arteries.

[Risk factors of atherosclerosis in end-stage renal disease patients].

[Vascular calcification and phosphate metabolism].

[Mechanism of vascular calcification].

[Close relationship between bone and vasculature].

[Measurement of serum MGP].

[Osteopontin and atherosclerosis].

Association of serum TRAIL level with coronary artery disease.

Fetuin-A is associated with calcified coronary artery disease.

Effects of pravastatin on serum osteoprotegerin levels in patients with hypercholesterolemia and type 2 diabetes.

Vascular calcification in chronic kidney disease.